IsoRay, Inc. (ISR) Signs European Distribution Agreement for GliaSite Radiation Therapy
IsoRay, Inc., a provider of innovative solutions for the treatment and diagnosis of disease using medical isotopes that represent significant advancements over existing technology, today announced an agreement with Karlheinz Goehl-Medizintechnik Goehl for the distribution of the GliaSite radiation therapy system in certain European markets. The GliaSite radiation therapy system includes a balloon catheter which is a unique technology that allows doctors to treat more brain cancer patients than brachytherapy or internal radiation therapy. "The GliaSite® system represents continued progress toward our goal of expanding the use of brachytherapy solutions to treat cancers throughout the entire body. This distribution agreement…